Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Research Report
Comprehensive Report on Maltodextrin (DB12583)
Section 1: Introduction and Executive Summary
1.1 Preamble
Maltodextrin (CAS Number: 9050-36-6; DrugBank ID: DB12583) is a substance of profound paradox in modern food science, nutrition, and pharmacology. It exists simultaneously as a high-performance ergogenic aid for elite athletes, a ubiquitous and functional additive in a vast array of processed foods, a common excipient in pharmaceutical formulations, and, increasingly, a subject of significant scientific concern for its potential role in gut dysbiosis and intestinal inflammation. This report aims to provide a definitive, multi-disciplinary monograph on maltodextrin, reconciling its varied and often conflicting roles. By synthesizing evidence from chemistry, industrial processing, food technology, sports science, and clinical research, this document presents a nuanced, evidence-based assessment of its complete profile, from molecular structure to its complex interactions with human physiology.
1.2 Executive Summary
This report provides a comprehensive analysis of maltodextrin, a polysaccharide derived from the partial hydrolysis of starch. A central finding is the critical distinction between two forms that share a name but possess opposite physiological functions: digestible maltodextrin and resistant maltodextrin (RMD).
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/09/24 | Not Applicable | Not yet recruiting | |||
2025/03/03 | Phase 2 | Recruiting | Nathan Brashares Sackett | ||
2024/06/06 | Phase 3 | Recruiting | |||
2024/06/03 | Phase 3 | Recruiting | |||
2024/05/31 | Phase 3 | Completed | |||
2023/10/27 | Phase 3 | Completed | |||
2022/06/13 | Phase 2 | Recruiting | Anders Fink-Jensen, MD, DMSci | ||
2022/01/12 | Phase 4 | Not yet recruiting | |||
2018/05/21 | Phase 2 | UNKNOWN | |||
2016/11/03 | Phase 2 | Withdrawn | Jeff Taekman, M.D. |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.
